SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-013295
Filing Date
2024-03-27
Accepted
2024-03-27 16:06:00
Documents
16
Period of Report
2024-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K toi-20240327.htm   iXBRL 8-K 29393
2 EX-99.1 item991-q42023earningsrele.htm EX-99.1 344403
7 LOGO image_0a.jpg GRAPHIC 14770
  Complete submission text file 0001628280-24-013295.txt   588442

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT toi-20240327.xsd EX-101.SCH 2306
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT toi-20240327_def.xml EX-101.DEF 15976
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT toi-20240327_lab.xml EX-101.LAB 27922
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT toi-20240327_pre.xml EX-101.PRE 16714
19 EXTRACTED XBRL INSTANCE DOCUMENT toi-20240327_htm.xml XML 4190
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 24790605
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)